The use of analytics and potency assays is now integral to the characterization of complex biological products, in addition to being essential for regulatory submissions and the maintenance of batch-to-batch consistency. The commitment to the consistency, safety, and efficacy of sophisticated therapies necessitates the introduction of a new generation of analytical tools and quality supports. The Cell & Gene Therapy forum will give opinions of the experts in analytical science, regulatory science, and manufacturing to present on current advancements in the standardization of assays, automation, and data-driven release. This session will assess novel approaches that improve knowledge of processes, qualify products in real-time, and strengthen the scientific basis for the worldwide accelerated, compliant delivery of therapies.